Bakiri F, Benmiloud M, Vallotton M B
J Clin Endocrinol Metab. 1983 May;56(5):1042-7. doi: 10.1210/jcem-56-5-1042.
To gain insight in the influence of the pituitary gland on the renin-angiotensin system plasma renin substrate (PRS) and the response of PRA to stimulation were studied in a homogeneous group of 20 female patients with the same etiology and degree of pituitary failure, before treatment (group P), after hydrocortisone substitution (group F), and after hydrocortisone and thyroid hormone treatment (group F + T). All patients were studied before and after each treatment by response to two stimulatory tests, acting through two different pathways; orthostasis test (O-T) and the furosemide test (Furo-T). Results were compared between groups, each patient serving as her own control, and with those obtained in a 12 healthy women control group (group C). The diet contained about 85 meq Na/day. Compared to group C (O-T response, 5.97 +/- 0.54 ng ml-1 h-1; Furo-T response, 6.71 +/- 0.82 ng ml-1 h-1; mean +/- SEM), PRA response to both tests was blunted in group P (O-T: 2.48 +/- 0.46, P less than 0.001; Furo-T: 3.02 +/- 0.53, P less than 0.001) and remained so in F (O-T: 2.18 +/- 0.40, P less than 0.001; Furo-T: 2.52 +/- 0.28, P less than 0.001), In group F + T, the response to both tests was greater than in P and F (O-T, 6.61 +/- 1.19; Furo-T, 4.36 +/- 0.44; 0.001 less than P less than 0.05). However, whereas the response to orthostasis is entirely normalized, the response to a diuretic remained significantly smaller than in group C (P less than 0.01). These improvements were observed without significant change in PRS concentration which remained low. We conclude that panhypopituitarism is accompanied by an altered renin angiotensin system. Basal levels of PRS and PRA are low and unresponsive to adequate stimulation. Whereas glucocorticoid therapy alone is without effect on this hyporeninism, addition of thyroid hormones completely normalized the response to orthostasis and significantly improved furosemide response.
为深入了解垂体对肾素 - 血管紧张素系统的影响,我们对20名病因和垂体功能减退程度相同的女性患者进行了研究,检测她们治疗前(P组)、氢化可的松替代治疗后(F组)以及氢化可的松和甲状腺激素治疗后(F + T组)的血浆肾素底物(PRS)和血浆肾素活性(PRA)对刺激的反应。所有患者在每次治疗前后均通过两种不同途径的刺激试验进行研究:立位试验(O - T)和速尿试验(Furo - T)。将各小组的结果进行比较,每位患者自身作为对照,并与12名健康女性对照组(C组)的结果进行比较。饮食中钠含量约为85 meq/天。与C组相比(O - T反应:5.97±0.54 ng ml⁻¹ h⁻¹;Furo - T反应:6.71±0.82 ng ml⁻¹ h⁻¹;均值±标准误),P组对两种试验的PRA反应均减弱(O - T:2.48±0.46,P<0.001;Furo - T:3.02±0.53,P<0.001),F组同样如此(O - T:2.18±0.40,P<0.001;Furo - T:2.52±0.28,P<0.001)。在F + T组,对两种试验的反应均大于P组和F组(O - T:6.61±1.19;Furo - T:4.36±0.44;0.001<P<0.05)。然而,尽管立位反应完全恢复正常,但对利尿剂的反应仍显著低于C组(P<0.01)。观察到这些改善的同时,PRS浓度无显著变化,仍维持在较低水平。我们得出结论,全垂体功能减退伴有肾素 - 血管紧张素系统改变。PRS和PRA的基础水平较低,对适当刺激无反应。单独使用糖皮质激素治疗对这种低肾素血症无效,添加甲状腺激素可使立位反应完全恢复正常,并显著改善速尿反应。